PRINCIPIA BIOPHARMA INC. Stock-Based Compensation
PRINCIPIA BIOPHARMA INC. reported Stock-Based Compensation of $11.34 million for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2020-08-06
- PRINCIPIA BIOPHARMA INC. share-based payment arrangement, noncash expense for the quarter ending 2020-06-30 was $6.95M, a 99.86% increase year-over-year.
- PRINCIPIA BIOPHARMA INC. share-based payment arrangement, noncash expense for the quarter ending 2020-03-31 was $4.39M, a 99.05% increase year-over-year.
- PRINCIPIA BIOPHARMA INC. share-based payment arrangement, noncash expense for the quarter ending 2019-12-31 was $3.25M, a 135.95% increase year-over-year.
- PRINCIPIA BIOPHARMA INC. share-based payment arrangement, noncash expense for the quarter ending 2019-09-30 was $3.25M, a 374.05% increase year-over-year.
- PRINCIPIA BIOPHARMA INC. share-based payment arrangement, noncash expense for fiscal 2019 was $12.18M, a 334.92% increase from fiscal 2018.
- PRINCIPIA BIOPHARMA INC. share-based payment arrangement, noncash expense for fiscal 2018 was $2.80M, a 172.74% increase from fiscal 2017.
- PRINCIPIA BIOPHARMA INC. share-based payment arrangement, noncash expense for fiscal 2017 was $1.03M, a 2.47% decline from fiscal 2016.
- PRINCIPIA BIOPHARMA INC. share-based payment arrangement, noncash expense for fiscal 2016 was $1.05M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2020-06-30 | $6.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $11.34M 10-Q · filed 2020-08-06 | $14.59M derived: sum of 3 quarters · filed 2020-08-06 | $17.84M derived: sum of 4 quarters · filed 2020-08-06 |
| 2020-03-31 | $4.39M 10-Q · filed 2020-05-06 | $7.64M derived: sum of 2 quarters · filed 2020-05-06 | $10.89M derived: sum of 3 quarters · filed 2020-05-06 | $14.37M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-12-31 | $3.25M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $6.50M derived: sum of 2 quarters · filed 2020-03-10 | $9.98M derived: sum of 3 quarters · filed 2020-08-06 | $12.18M 10-K · filed 2020-03-10 |
| 2019-09-30 | $3.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $6.73M derived: sum of 2 quarters · filed 2020-08-06 | $8.93M 10-Q · filed 2019-11-05 | $10.31M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-06-30 | $3.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $5.68M 10-Q · filed 2020-08-06 | $7.06M derived: sum of 3 quarters · filed 2020-08-06 | $7.74M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $2.21M 10-Q · filed 2020-05-06 | $3.58M derived: sum of 2 quarters · filed 2020-05-06 | $4.27M derived: sum of 3 quarters · filed 2020-05-06 | $4.64M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $2.06M derived: sum of 2 quarters · filed 2020-03-10 | $2.44M derived: sum of 3 quarters · filed 2020-03-10 | $2.80M 10-K · filed 2020-03-10 |
| 2018-09-30 | $686.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $1.06M derived: sum of 2 quarters · filed 2019-11-05 | $1.42M 10-Q · filed 2019-11-05 | $1.71M derived: sum of 4 quarters · filed 2020-03-10 |
| 2018-06-30 | $372.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $738.00K 10-Q · filed 2019-08-08 | $1.02M derived: sum of 3 quarters · filed 2020-03-10 | |
| 2018-03-31 | $366.00K 10-Q · filed 2019-05-07 | $650.00K derived: sum of 2 quarters · filed 2020-03-10 | ||
| 2017-12-31 | $284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $1.03M 10-K · filed 2020-03-10 | ||
| 2017-09-30 | $743.00K 10-Q · filed 2018-11-06 | |||
| 2016-12-31 | $1.05M 10-K · filed 2019-03-19 |